Thought Leadership
At NDA our experts stay abreast with the evolving environment and the new regulatory requirements that it gives rise to. One of the results of these activities is a stream of articles, commentaries and white papers that we publish for the benefit of our clients and followers. It captures the state of the art of our industry today.
We call it Thought Leadership.
Articles and White Papers
Service:
Scientific:
Sort by:
All services
Development Strategy
Medical Devices
Pharmacovigilance
NDA Advisory Board
Strategic Communications
Regulatory
Quality & Compliance
All expertise
Oncology
Vaccine
Immunogenicity
HTA
In-Vitro Diagnostics
Non-Clinical
Cell and Gene Therapy
Biostatistics
Cardiology
ATMP
Rare Disease
Market Access
CMC
Clinical
Paediatric
Acceleration Strategies
Medical Devices
Quality
Patient Safety
11-05-2021
The UK regulatory landscape: Gateways leading to new beginnings
Dr Thomas Lönngren provides his perspective and early insights on the new UK Regulatory framework implemented by the MHRA.
05-05-2021
NDA Webinar: Clinical and Regulatory strategies to avoid pitfalls in clinical trials session 2
In this webinar Dr Steffen Thirstrup, Advisory Board Director at NDA addresses why, when, and how to interact with the regulatory agencies to optimize the success of clinical development of a new medicinal product.
05-05-2021
NDA Webinar: Clinical and Regulatory strategies to avoid pitfalls in clinical trials session 1
In this webinar Dr Steffen Thirstrup, Advisory Board Director at NDA presents the fundamentals of designing a successful clinical trial.
21-04-2021
NDA Webinars Project Orbis: What you need to know
In this webinar our Senior Consultant and Project Orbis Lead, Claudia Reichle provides a closer look at Project Orbis and discusses what you should think about if you are offered the possibility to take part.
31-03-2021
NDA Webinars UK Regulatory Landscape post Brexit
In this webinar, Dr Thomas Lönngren and Patrick Mumo provide early initial insights into the changing UK regulatory landscape post brexit as the industry continues to adapt.
24-03-2021
Addressing the challenges of GTMPs
Dr Paula Salmikangas and Dr Björn Carlsson address the challenges related to the development of novel gene therapies.